<DOC>
	<DOCNO>NCT03022162</DOCNO>
	<brief_summary>Since introduction 1970s , Paclitaxel use effective anticancer agent lung , breast , ovarian , leukopenia liver cancer . But , Paclitaxel-induced peripheral neuropathy major dose-limiting side effect paclitaxel.Paclitaxel induce peripheral neuropathy commonly present 1 . Pain 2 . Burning , 3 . Tingling ( `` pin needle '' feel ) electric/shock-like pain , 4 . Hyperalgesia , 5 . Allodynia , 6 . Increased sensitivity cold heat These symptom classically see symmetrically distal extremity ( glove stock distribution ) . Most adverse effect associate chemotherapy ameliorate cessation therapy , CIPN may persist longterm , 30 % patient CIPN relate symptom beyond 6 month completion chemotherapy7.Understanding epidemiology neuropathic pain breast cancer patient high clinical public health significance .</brief_summary>
	<brief_title>Prevalence Paclitaxel Induced CIPN-Related Pain CIPN Indian Patients With Breast Cancer</brief_title>
	<detailed_description>PRIMARY AIM / OBJECTIVE : Our study aim observe prevalence CIPN-related pain cancer breast patient receive Paclitaxel base adjuvant chemotherapy define CIPN-related pain - `` possible '' neuropathic pain patient score 12 Leeds Assessment Neuropathic Symptoms Signs pain scale ( LANSS ) . SECONDARY AIM / OBJECTIVE Since introduction 1970s , Paclitaxel use effective anticancer agent lung , breast , ovarian , leukopenia liver cancer . But , Paclitaxel-induced peripheral neuropathy major dose-limiting side effect paclitaxel.Paclitaxel induce peripheral neuropathy commonly present 1 . Pain 2 . Burning , 3 . Tingling ( `` pin needle '' feel ) electric/shock-like pain , 4 . Hyperalgesia , 5 . Allodynia , 6 . Increased sensitivity cold heat These symptom classically see symmetrically distal extremity ( glove stock distribution ) . Most adverse effect associate chemotherapy ameliorate cessation therapy , CIPN may persist longterm , 30 % patient CIPN relate symptom beyond 6 month completion chemotherapy7.Understanding epidemiology neuropathic pain breast cancer patient high clinical public health significance . MATERIALS &amp; METHODS : The cohort consist woman early breast cancer ( stage I III ) receive Paclitaxel chemotherapy breast cancer per Institutional guideline within precede two year . History suggestive pre-existing neuropathy note . 1 . All patient ( fulfill inclusion criterion ) visit Tata Memorial hospital Feb2017 2016 June 2017 examine Medical Oncology OPD one investigator current CIPN CIPN-related pain score document use NCI-CTCAE LANSS scale . Then , patient question thepresence similar neuropathic symptom start , start Paclitaxel chemotherapy reply record . 2 . Patients receive adjuvant chemotherapy Paclitaxel could complete chemotherapy due Paclitaxel induce adverse effect peripheral neuropathy eg hypersensitivity Paclitaxel screen data exclude final data assessment . 2 . Use 1 . Acetyl-L-carnitine ( ALC ) 2 . Amifostine 3 . Amitriptyline 4 . CaMg 5 . Diethyldithio-carbamate ( DDTC ) 6 . Glutathione ( GSH ) 7 . Nimodipine 8 . All-trans-retinoic acid 9. rhuLIF 10 . Vitamin E Paclitaxel chemotherapy note base history examination chart . For CIPN-related pain : The Leeds Assessment Neuropathic Symptoms Signs pain scale ( LANSS ) simple valid 7-item tool identify patient whose pain dominate neuropathic mechanism . Each item binary response ( yes ) presence symptom ( 5 item ) clinical sign ( 2 item ) . If score &gt; 12 , neuropathic mechanism likely contribute patient 's pain . NCI-CTCAE : The National Cancer Institute - Common Terminology Criteria Adverse Events v4.0 , NCI-CTCAE recently update 2010 , use grade CIPN . The CTCAE display Grades 1 5 unique clinical description severity CIPN . Paclitaxel induce CIPN define NCI-CTCAE Grade 2 .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>1 . Histopathologically confirm Primary breast cancer 2 . Patients receive adjuvant chemotherapy Paclitaxel complete Paclitaxel chemotherapy within precede 2 year i.e . 1stAugust 2014 31st July 2016 . 1 . Age 18 year 2 . On current Paclitaxel chemotherapy 3 . Patients radiological evidence bone metastasis .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Neuropathic Pain , Paclitaxel , CIPN</keyword>
</DOC>